Abstract

Recently, some studies have applied the graph theory in brain network analysis in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). However, relatively little research has specifically explored the properties of the metabolic network in apolipoprotein E (APOE) ε4 allele carriers. In our study, all the subjects, including ADs, MCIs and NCs (normal controls) were divided into 165 APOE ε4 carriers and 165 APOE ε4 noncarriers. To establish the metabolic network for all brain regions except the cerebellum, cerebral glucose metabolism data obtained from FDG-PET (18F-fluorodeoxyglu-cose positron emission tomography) were segmented into 90 areas with automated anatomical labeling (AAL) template. Then, the properties of the networks were computed to explore the between-group differences. Our results suggested that both APOE ε4 carriers and noncarriers showed the small-world properties. Besides, compared with APOE ε4 noncarriers, the carriers showed a lower clustering coefficient. In addition, significant changes in 6 hub brain regions were found in between-group nodal centrality. Namely, compared with APOE ε4 noncarriers, significant decreases of the nodal centrality were found in left insula, right insula, right anterior cingulate, right paracingulate gyri, left cuneus, as well as significant increases in left paracentral lobule and left heschl gyrus in APOE ε4 carriers. Increased local short distance interregional correlations and disrupted long distance interregional correlations were found, which may support the point that the APOE ε4 carriers were more similar with AD or MCI in FDG uptake. In summary, the organization of metabolic network in APOE ε4 carriers indicated a less optimal pattern and APOE ε4 might be a risk factor for AD.

Highlights

  • Alzheimer’s disease (AD) is considered with progressive memory loss and cognitive decline

  • FDG-PET Metabolic Networks in Apolipoprotein E ε4 Allele Carriers study on the relationship between cerebrovascular defects and AD, which may be associated with the development in AD [3]

  • By computing the partial correlation coefficients between FAQ scores and metabolic values in apolipoprotein E (APOE) ε4 carriers, we found significant correlations in left rolandic operculum and left superior parietal gyrus

Read more

Summary

Introduction

Alzheimer’s disease (AD) is considered with progressive memory loss and cognitive decline. The ε4 allele of apolipoprotein E (APOE) might be the strongest genetic risk factor [1, 2]. The frequency of the ε4 allele of apolipoprotein E (APOE) was suggested in a high level in northern regions of Europe and ε4 allele existed in roughly 20– 25% of North Americans and Europeans[4, 5]. This result provided the support to study the individuals with apolipoprotein E (APOE) in a large sample size[5]. A univariate logistic regression analysis found that APOE ε4 was significantly related to AD predictability [6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call